v.231201
Showing details for project SYSMHC00005
SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
SYSMHC00005_Fib |
4 |
Human |
|
|
HLA-A03_01,HLA-A23_01,HLA-B08_01,HLA-B15_18,HLA-C07_02,HLA-C07_04 |
SYSMHC00005_HCC1143 |
3 |
Human |
|
|
HLA-A31_01,HLA-B35_08,HLA-B37_01,HLA-C04_01,HLA-C06_02 |
SYSMHC00005_HCC1937 |
4 |
Human |
|
|
HLA-A23_01,HLA-A24_02,HLA-B07_02,HLA-B40_01,HLA-C03_04,HLA-C07_02 |
SYSMHC00005_HCT116 |
4 |
Human |
|
|
HLA-A01_01,HLA-A02_01,HLA-B45_01,HLA-B18_01,HLA-C05_01,HLA-C07_01 |
SYSMHC00005_JY |
3 |
Human |
|
|
HLA-A02_01,HLA-B07_02,HLA-C07_02 |
SYSMHC00005_SupB15-RT |
4 |
Human |
|
|
HLA-A03_01,HLA-A11_01,HLA-B51_01,HLA-B52_01,HLA-C12_04,HLA-C14_02 |
SYSMHC00005_SupB15-WT |
4 |
Human |
|
|
HLA-A03_01,HLA-A11_01,HLA-B51_01,HLA-B52_01,HLA-C12_04,HLA-C14_02 |
Detailed view of sample SYSMHC00005_SupB15-WT
ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
SYSMHC00005 |
SYSMHC00005_SupB15-WT |
SYSMHC00005_20120726_EXQ1_MiBa_SA_SupB15-WT_mHLA-5.raw |
Human |
In vitro |
Blood |
Supb15-wt |
suspension |
|
B-cell leukemia |
class I |
HLA-A03_01,HLA-A11_01,HLA-B51_01,HLA-B52_01,HLA-C12_04,HLA-C14_02 |
25576301 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
nanoflow HPLC (Proxeon Biosystems, Thermo Fisher Scientific, Bremen, Germany) |
no |
DDA |
HCD |
2-30% ACN |
90 |
75μm id 2 cm |
1 |
SYSMHC00005 |
SYSMHC00005_SupB15-WT |
SYSMHC00005_20120726_EXQ1_MiBa_SA_SupB15-WT_mHLA-4.raw |
Human |
In vitro |
Blood |
Supb15-wt |
suspension |
|
B-cell leukemia |
class I |
HLA-A03_01,HLA-A11_01,HLA-B51_01,HLA-B52_01,HLA-C12_04,HLA-C14_02 |
25576301 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
nanoflow HPLC (Proxeon Biosystems, Thermo Fisher Scientific, Bremen, Germany) |
no |
DDA |
HCD |
2-30% ACN |
90 |
75μm id 2 cm |
2 |
SYSMHC00005 |
SYSMHC00005_SupB15-WT |
SYSMHC00005_20120726_EXQ1_MiBa_SA_SupB15-WT_mHLA-2.raw |
Human |
In vitro |
Blood |
Supb15-wt |
suspension |
|
B-cell leukemia |
class I |
HLA-A03_01,HLA-A11_01,HLA-B51_01,HLA-B52_01,HLA-C12_04,HLA-C14_02 |
25576301 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
nanoflow HPLC (Proxeon Biosystems, Thermo Fisher Scientific, Bremen, Germany) |
no |
DDA |
HCD |
2-30% ACN |
90 |
75μm id 2 cm |
3 |
SYSMHC00005 |
SYSMHC00005_SupB15-WT |
SYSMHC00005_20120726_EXQ1_MiBa_SA_SupB15-WT_mHLA-3.raw |
Human |
In vitro |
Blood |
Supb15-wt |
suspension |
|
B-cell leukemia |
class I |
HLA-A03_01,HLA-A11_01,HLA-B51_01,HLA-B52_01,HLA-C12_04,HLA-C14_02 |
25576301 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
nanoflow HPLC (Proxeon Biosystems, Thermo Fisher Scientific, Bremen, Germany) |
no |
DDA |
HCD |
2-30% ACN |
90 |
75μm id 2 cm |
4 |